Cargando…
Carglumic Acid Treatment of a Patient with Recurrent Valproic Acid-induced Hyperammonemia: A Rare Case Report
Valproic acid, first manufactured as an anticonvulsant, is commonly used to treat both neurological and psychiatric conditions. A rare and deadly side effect of this medication is hyperammonemia, presenting as lethargy, confusion, seizure, and, ultimately, coma. In rare circumstances, hyperammonemia...
Autores principales: | Sattar, Yasar, Wasiq, Saad, Yasin, Waqas, Khan, Ali M, Adnan, Mahwish, Shrestha, Shristi, Patel, Nirav B, Latchana, Sharaad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235635/ https://www.ncbi.nlm.nih.gov/pubmed/30443462 http://dx.doi.org/10.7759/cureus.3292 |
Ejemplares similares
-
Carglumic acid: an additional therapy in the treatment of organic acidurias with hyperammonemia?
por: Levrat, Virginie, et al.
Publicado: (2008) -
New developments in the treatment of hyperammonemia: emerging use of carglumic acid
por: Daniotti, Marta, et al.
Publicado: (2011) -
Use of carglumic acid in valproate‐induced hyperammonemia: 25 pediatric cases
por: Palomino Pérez, Laura María, et al.
Publicado: (2020) -
Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency
por: Häberle, Johannes
Publicado: (2011) -
Hyperammonemia Associated with Valproic Acid Concentrations
por: Vázquez, Marta, et al.
Publicado: (2014)